Thomas Leggett - Net Worth and Insider Trading
Thomas Leggett Net Worth
The estimated net worth of Thomas Leggett is at least $0 dollars as of 2024-06-14. Thomas Leggett is the CFO of Black Diamond Therapeutics Inc and owns about 0 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $0. Details can be seen in Thomas Leggett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Leggett has not made any transactions after 2021-01-08 and currently still holds the listed stock(s).
Transaction Summary of Thomas Leggett
Thomas Leggett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Leggett owns 3 companies in total, including Black Diamond Therapeutics Inc (BDTX) , Axcella Health Inc (AXLA) , and Research Alliance Corp II (RACB) .
Click here to see the complete history of Thomas Leggett’s form 4 insider trades.
Insider Ownership Summary of Thomas Leggett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2021-01-08 | Chief Financial Officer |
| AXLA | Axcella Health Inc | 2019-05-08 | SVP Finance & CFO |
| RACB | Research Alliance Corp II | 2021-03-17 | director |
Thomas Leggett Latest Holdings Summary
Thomas Leggett currently owns a total of 1 stock. Thomas Leggett owns 0 shares of Black Diamond Therapeutics Inc (BDTX) as of January 8, 2021, with a value of $0.
Latest Holdings of Thomas Leggett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BDTX | Black Diamond Therapeutics Inc | 2021-01-08 | 0 | 6.18 | 0 |
Holding Weightings of Thomas Leggett
Thomas Leggett Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Leggett has made a total of 5 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 3,000 shares on January 8, 2021, which brought Thomas Leggett around $101,820.
Insider Trading History of Thomas Leggett
- 1
Thomas Leggett Trading Performance
Thomas Leggett Ownership Network
Thomas Leggett Owned Company Details
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Thomas Leggett is the Chief Financial Officer of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , director & 10 percent owner Ali Behbahani , and director & See Remarks David M. Epstein .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Thomas Leggett made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
Thomas Leggett Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Leggett. You might contact Thomas Leggett via mailing address: C/o Axcella Health Inc., 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
